Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats

Inflammopharmacology

Volumn 15, Issue 6, 2007, Pages 266-272

  Nishio, H ^a   Hayashi, Y ^a   Terashima, S ^a   Takeuchi, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MYELOPEROXIDASE; PRANLUKAST;

ARTICLE; BACTERIAL TRANSLOCATION; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE MOTILITY; MALE; MUCOUS CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIAL TRANSLOCATION; CAPILLARY PERMEABILITY; CHROMONES; DINOPROSTONE; ENTEROBACTERIACEAE; GASTROINTESTINAL MOTILITY; INDOMETHACIN; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MALE; MUCUS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; ULCER;

EID: 38849149614     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-1585-1     Document Type: Article

References (46)

1. Arumugam, T. V., Arnold, N., Proctor, L. M. et al. (2003) Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist. Br J Pharmacol, 140, 71-80.
2. Asko H., Kubes P., Wallce J. (1993) Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol, 262, G903-8.
3. Azumi, Y., Ohara, S., Ishihara, K. et al. (1981) Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut, 21, 533-536.
4. Bisgaard, H. (2001) Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma, Allergy 56 Suppl 66, 7-11.
5. Boughton-Smith, N. K., Evans, S. M., Laszlo, F. et al. (1993) The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol, 110, 1189-1195.
6. Bradley, P. P., Priebat, D. A., Christensen, R. D. et al. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol, 78, 206-209.
7. Brown, J. F., Tepperman, B. L., Hanson, P. J. et al. (1992) Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun, 184, 680-685.
8. Dahlen, S. E., Hedqvist, P., Hammarstrom, S. et al. (1980) Leukotrienes are potent constrictors of human bronchi. Nature, 288, 484-486.
9. Drazen, J. M. (1998) Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med, 158, 193-200.
10. Drazen, J. M., Austen, K. F., Lewis, R. A. et al. (1980) Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA, 177, 4354-4358.
11. Futaki, N., Takahashi, S., Yokoyama, M. et al. (1994) NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.
12. Gyomber E, Vattay P, Szabo S. et al. (1996) Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat. J Gastroenterol Hepatol, 11, 922-7.
13. Hanna, C. J., Bach, M. K., Pare, P. D. et al. (1981) Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature, 290, 343-344.
14. Henderson, W. R. (1994) The role of leukotrienes in inflammation. Ann Intern Med, 121, 684-697.
15. Holma, R., Salmenpera, P., Riutta, A. et al. (2001) Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol, 429, 309-318.
16. Katayama, S., Shionoya, H. and Ohtake, S. (1978) A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol, 22, 89-101.
17. Kato, S., Tanaka, A., Kunikata, T. et al. (2000) Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion, 61, 39-46.
18. Kim, J. H., Tagari, P., Griffiths, A. M. et al. (1995) Levels of peptidoleukotriene E4 are elevated in active Crohn's disease. J Pediatr Gastroenterol Nutr, 20, 403-407.
19. Kobayashi, K., Fukuda, T., Higuchi, K. et al. (1993) Role of leukotrienes in indomethacin-induced mucosal damage in rats. J Clin Gastroenterol, 17 (Suppl 1), S11-14.
20. Konaka, A., Kato, S., Tanaka, A. et al. (1999) Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res, 40, 517-524.
21. Kunikata, T., Tanaka, A., Miyazawa, T. et al. (2002) 16,16-dimetyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci, 47, 894-904.
22. Lam, B.K. (1997) Leukotriene C4 synthase: a critical enzyme for the biosynthesis of SRS-A. Front Biosci, 2, 380-386.
23. Lewis, R. A., Austen, K. F., Soberman, R. J. (1990) Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases. New Engl J Med, 323, 645-655.
24. Mahgoub, A. A., El-Medany, A. A., Hager, H. H. et al. (2003) Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett, 145, 79-87.
25. Marom, Z., Shelhamer, J. H., Bach, M. K. et al. (1982) Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis, 126, 449-451.
26. Miller, M. J., Thompson, J. H., Zhang, X. J. et al. (1995) Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology, 109, 1475-1483.
27. Murphy, R. C., Hammarstrom, S., Samuelsson, B. (1979) Leukotriene C: a slow-reacting substance from murine mastocytoma cell. Proc Natl Acad Sci USA, 76, 4275-4279.
28. Penrose, J. F., Austen, K. F. (1999) The biochemical, molecular, and genomic aspects of leukotriene C4 synthase. Proc Assoc Am Physicians, 111, 537-546.
29. Peskar, B. M. (1991) Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach. Gastroenterology, 100, 619-626.
30. Piper, P. J. (1975) Formation and actions of leukotrienes. Physiol Rev, 64, 744-61.
31. Rainsford K. D. (1986) Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. Pharmacol Res Commun, 18 , 209-15.
32. Robert, A. (1975) An intestinal disease produced experimentally by a prostaglandin deficiency. Gastroenterology, 69, 1045-1047.
33. Samuelsson, B. (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568-575.
34. Samuelsson, B., Dahlen, S. E., Lindgren, J. A. et al. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science, 237, 1171-1176.
35. Shimizu, T., Wolfe, L. S. (1990) Arachidonic acid cascade and signal transduction. J Neurochem, 55, 1-15.
36. Spada, C. S., Woodward, D. F., Hawley, S. B. et al. (1986) Leukotrienes cause eosinophil emigration into conjunctival tissue. Prostaglandins, 31, 795-809.
37. Takeuchi, K., Furukawa, O., Nishiwaki, H. et al. (1987) 16,16-Dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats: Possible role of the increased mucosal vascular permeability. Gastroenterology, 93, 1276-1286.
38. Takeuchi, K., Hase, S., Mizoguchi, H. et al. (2001) Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid. J Physiol Paris, 95, 51-57.
39. Takeuchi, K., Miyazawa, T., Tanaka, A. et al. (2002) Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion, 66, 30-41.
40. Wallace, J. L., Granger, D. N. (1992) Pathogenesis of NSAID gastropathy: are neutrophils the culpris? Trend Pharmacol Sci, 3, 129-131.
41. Weissenborn, U., Maedge, S., Buettner, D. et al. (1985) Indomethacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology, 30, 32-39.
42. Welsch, D. J., Creely, D. P., Hauser, S. D. et al. (1981) Molecular cloning and expression of human leukotriene-C4 synthase. Proc Natl Acad Sci USA, 91, 9745-9749.
43. Whittle, B. J. (1981) Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 80, 94-98.
44. Whittle, B. J., Laszlo, F., Evans, S. M. et al. (1995) Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol, 116, 2286-2290.
45. Yamada, T., Deitch, E., Specian, R. D. et al. (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation, 17, 641-662.
46. Yasuhiro, T., Konaka, A., Ukawa, H. et al. (1997) Role of nitric oxide in pathogenesis of gastric mucosal damage induced by compound 48/80 in rats. J Physiol Paris, 91, 131-138.